000079576 001__ 79576
000079576 005__ 20230921135428.0
000079576 0247_ $$2doi$$a10.1177/2048004019848273
000079576 0248_ $$2sideral$$a111646
000079576 037__ $$aART-2019-111646
000079576 041__ $$aeng
000079576 100__ $$0(orcid)0000-0001-9962-3387$$aFrutos Pérez-Surio, Alberto$$uUniversidad de Zaragoza
000079576 245__ $$aPharmaceutical intervention after evaluation of the risk of ictus in elderly patients institutionalized with atrial fibrillation
000079576 260__ $$c2019
000079576 5060_ $$aAccess copy available to the general public$$fUnrestricted
000079576 5203_ $$aObjectives: To evaluate the risk of having a stroke and the risk of bleeding in institutionalized patients with atrial fibrillation. Atrial fibrillation is a common cardiac arrhythmia associated with increased morbidity and mortality. It is necessary to develop pharmacotherapy plans to minimize the risk.
Design: A prospective study.
Setting: Institutionalized patients.
Participants: Inclusion criteria were: patients diagnosed with atrial fibrillation, with or without treatment for the prevention of stroke.
Main outcome measures: The evaluation of the CHA2DS2-VASc criteria was performed. The risk of hemorrhage was assessed using the HAS-BLED scale, based on the risk factors associated with the probability of bleeding. Results: We included 53 patients (86.4 ` 6.4 years, 30.2% men). Of these, 37 (69.8%) were correctly anticoagulated. Of the remaining, 5 patients (31.2%) did not have any type of anticoagulant or antiaggregant treatment and 11 (68.7%) were treated with antiaggregant alone. The pharmaceutical intervention was performed in patients who did not meet stroke criteria. Of the untreated patients: two died before the intervention, two were recommended to be referred to cardiology and in one there was no intervention because of very advanced age. In the antiaggregant patients, it was decided not to modify the treatment. The reasons were: high risk of bleeding, very advanced age, advanced dementia or terminal illness, moderate risk of stroke, and clotting factor deficiency.
Conclusions: The risk of stroke in elderly patients with atrial fibrillation is high, so it is important to control the risk factors.
000079576 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000079576 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000079576 700__ $$aLozano Ortiz, Roberto
000079576 700__ $$aMartínez Crespo, Alejandro
000079576 7102_ $$11008$$2615$$aUniversidad de Zaragoza$$bDpto. Microb.Med.Pr.,Sal.Públ.$$cÁrea Medic.Prevent.Salud Públ.
000079576 773__ $$g8 (2019), 1-5$$pJRSM cardiovasc. dis.$$tJRSM Cardiovascular Disease$$x2048-0040
000079576 8564_ $$s226140$$uhttps://zaguan.unizar.es/record/79576/files/texto_completo.pdf$$yVersión publicada
000079576 8564_ $$s101703$$uhttps://zaguan.unizar.es/record/79576/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000079576 909CO $$ooai:zaguan.unizar.es:79576$$particulos$$pdriver
000079576 951__ $$a2023-09-21-13:29:34
000079576 980__ $$aARTICLE